ALKBH5 and colorectal carcinoma: ALKBH5 demethylates axis inhibition protein 2 (AXIN2) mRNA, leading to its degradation and Wnt/β‐catenin overactivation, inducing Dickkopf‐related protein 1 (DKK1) and recruiting MDSCs and, therefore, driving CRC immunosuppression and tumorigenesis.